If you purchased or acquired securities in Brainstorm between August 15, 2022 and September 27, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/BCLI. There is no cost or obligation to you. NEW… Continue reading BRAINSTORM SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Brainstorm To Contact Him Directly To Discuss Their Options
Category: Newswire
FMC SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In FMC To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in FMC between November 2, 2022 and October 30, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/FMC. There is no cost or obligation to you. NEW… Continue reading FMC SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In FMC To Contact Him Directly To Discuss Their Options
DOCGO SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In DocGo To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in DocGo between November 8, 2022 and September 17, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/DCGO. There is no cost or obligation to you. NEW… Continue reading DOCGO SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In DocGo To Contact Him Directly To Discuss Their Options
LI-CYCLE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Li-Cycle To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Li-Cycle between June 14, 2022 and October 23, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/LICY. There is no cost or obligation to you. NEW… Continue reading LI-CYCLE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Li-Cycle To Contact Him Directly To Discuss Their Options
OUTLOOK SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Outlook To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Outlook between December 29, 2022 and August 29, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/OTLK. There is no cost or obligation to you. NEW… Continue reading OUTLOOK SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Outlook To Contact Him Directly To Discuss Their Options
New Analyses from Pivotal Phase 3 INDIGO Study Reinforce Vorasidenib’s Potential to Change the Treatment Paradigm for IDH-Mutant Diffuse Glioma
Late-breaking analysis from pivotal INDIGO Phase 3 trial demonstrates vorasidenib led to tumor shrinkage in IDH1/2-mutant diffuse glioma First data from Phase 1 trial show the safety and tolerability of vorasidenib plus KEYTRUDA® (pembrolizumab) in recurrent or progressive enhancing IDH1-mutant diffuse astrocytomas BOSTON, Nov. 18, 2023 /PRNewswire/ — New data from Servier’s clinical development program for vorasidenib… Continue reading New Analyses from Pivotal Phase 3 INDIGO Study Reinforce Vorasidenib’s Potential to Change the Treatment Paradigm for IDH-Mutant Diffuse Glioma
Rotterdam The Hague Airport accelerates sustainable fuel blending
ROTTERDAM, The Netherlands, Nov. 17, 2023 /PRNewswire/ — Yesterday, Shell and Rotterdam The Hague Airport (RTHA) signed a long-term agreement to blend sustainable aviation fuel on all aircraft fuelled at the airport, starting in 2024. On top of the European blending mandate of 6%, the airport will accelerate its efforts by setting itself a minimum… Continue reading Rotterdam The Hague Airport accelerates sustainable fuel blending
Electric Motor Market to Reach $373.9 billion, Globally, by 2032 at 9.5% CAGR: Allied Market Research
The electric motor market has witnessed growth due to increase in demand for energy-efficient electric motors, increased sales of consumer electronics & appliances in developing countries, and rise in demand for electric vehicles. WILMINGTON, Del., Nov. 17, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “Electric Motor Market by Type (Alternate Current (AC) Motor, and… Continue reading Electric Motor Market to Reach $373.9 billion, Globally, by 2032 at 9.5% CAGR: Allied Market Research
Guizhou Satellite TV unveils the hidden Ecological Attractions in Bijie, Guizhou
GUIYANG, China, Nov. 17, 2023 /PRNewswire/ — Bijie, located in the northwestern part of Guizhou, has a humid subtropical monsoon climate, with a cool summer and mild winter. There are endless mountains, lush forests, blue skies and vast grasslands, which can be seen as a microcosm of the ecology of Guizhou. Every winter, more than… Continue reading Guizhou Satellite TV unveils the hidden Ecological Attractions in Bijie, Guizhou
Trip.com Group Forms Partnership with China International Culture Association
Trip.com Group Appointed As Partner of Nihao! China to Promote Inbound Tourism SINGAPORE, Nov. 17, 2023 /PRNewswire/ — Trip.com Group has signed a three-year Memorandum of Understanding with the China International Culture Association to promote inbound tourism. Mr James Liang, Co-founder and Chairman of Trip.com Group and Mr Bo Sun, Chief Marketing Officer of Trip.com… Continue reading Trip.com Group Forms Partnership with China International Culture Association